DouglasJamesScothornMDPhD

Pediatric Hematology & Oncology • Asheville, NC

Physician

Join to view full profile

Dr. Scothorn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Scothorn's full profile

Already have an account?

Office
21 Hospital Drive
Asheville, NC 28801
Phone+1 828-213-9770

Fax+1 828-213-9771
Is this information wrong?

Education & Training

University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2000 - 2002
University of Texas Southwestern Medical CenterResidency, Pediatrics, 1997 - 2000
Vanderbilt University School of MedicineClass of 1997

Certifications & Licensure

NC State Medical License 2006 - 2024
TX State Medical License 1998 - 2007
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Start of enrollment: 2012 Feb 21
Active, not recruiting
Phase 3
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
Active, not recruiting
Phase 2
Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma Start of enrollment: 2014 Aug 01
Completed
Phase 2
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Jul 11
Active, not recruiting
Phase 2, Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Join now to see all

Publications & Presentations

PubMed

6 citations
The diagnostic utility of routine chest radiography in the evaluation of the initial fever in patients undergoing hematopoietic stem cell.
Jennifer Cox, James DeMasi, Susan McCollom, Gevel Jackson, Douglas Scothorn, Victor M. Aquino> ;Pediatric Blood & Cancer. 2011 Oct 1
93 citations
Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study o...
Monica L. Hulbert, Douglas J. Scothorn, Julie A. Panepinto, J. Paul Scott, George R. Buchanan, Sharada A. Sarnaik, Robert J. Fallon, Jen Yih Chu, Winfred C. Wang, Jame...> ;The Journal of Pediatrics. 2006 Nov 1
107 citations
Antitumor Effects of a Monoclonal Antibody that Binds Anionic Phospholipids on the Surface of Tumor Blood Vessels in Mice
Sophia Ran, Jin He, Xianming Huang, Melina Soares, Douglas J. Scothorn, Philip E. Thorpe> ;Clinical Cancer Research. 2005 Feb 15
Rapidly fatal acute bacterial myocarditis in a nonneutropenic child with acute lymphoblastic leukemia in remission.
Douglas J. Scothorn, Naomi J. Winick, Charles F. Timmons, Naomiand Victor M. Aquino> ;Journal of Pediatric Hematology/oncology. 2002 Nov 1
170 citations
Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke.
Douglas J. Scothorn, Cynthia L. Price, Daniel Schwartz, Cindy Terrill, George R. Buchanan, Wanda Shurney, Ingrid Sarniak, Robert J. Fallon, Jen Yih Chu, Charles H. Peg...> ;The Journal of Pediatrics. 2002 Mar 1
11 citations
How common is precocious puberty in patients with Williams syndrome
Douglas J. Scothorn, Merlin G. Butler> ;Clinical Dysmorphology. 1997 Jan 1
4 citations
SYNTHESIS AND CHARACTERIZATION OF A NOVEL SPIN-LABELED AFFINITY PROBE OF HUMAN ERYTHROCYTE BAND 3 : CHARACTERISTICS OF THE STILBENEDISULFONATE BINDING SITE
Douglas J. Scothorn, Walter E. Wojcicki, Eric J. Hustedt, A.H. Beth, Charles E. Cobb> ;Biochemistry. 1996 May 28
Join now to see all

Professional Memberships

American Academy of Pediatrics - AAP
Fellow
American Society of Clinical Oncology - ASCO
Member
American Society of Hematology - ASH
Member
American Society of Pediatric Hematology/Oncology
Member

Hospital Affiliations

Mission HospitalAsheville, North Carolina

DouglasJamesScothornMDPhD

Dr. Scothorn is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Professional Memberships

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.